Next Article in Journal / Special Issue
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
Previous Article in Journal
Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice
Previous Article in Special Issue
A Tumor-Immune Interaction Model for Synergistic Combinations of Anti PD-L1 and Ionizing Irradiation Treatment
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(10), 974; https://doi.org/10.3390/pharmaceutics12100974
Action Date Notes Link
article pdf uploaded. 15 October 2020 15:27 CEST Version of Record https://www.mdpi.com/1999-4923/12/10/974/pdf-vor
article supplementary file uploaded. 15 October 2020 15:27 CEST - https://www.mdpi.com/1999-4923/12/10/974#supplementary
article xml file uploaded 21 October 2020 04:27 CEST Original file -
article xml uploaded. 21 October 2020 04:27 CEST Update https://www.mdpi.com/1999-4923/12/10/974/xml
article pdf uploaded. 21 October 2020 04:27 CEST Updated version of record https://www.mdpi.com/1999-4923/12/10/974/pdf
article html file updated 21 October 2020 05:09 CEST Original file -
article html file updated 22 July 2022 21:12 CEST Update https://www.mdpi.com/1999-4923/12/10/974/html
Back to TopTop